Tocilizumab

Details

Files

Generic Name:

Tocilizumab

Project Status:

Complete

Therapeutic Area:

Arthritis, juvenile idiopathic

Manufacturer:

Hoffman-La Roche Ltd.

Call for patient/clinician input open:

January 30, 2012

Brand Name:

Actemra

Project Line:

Reimbursement Review

Project Number:

SR0267-000

Call for patient/clinician input closed:

February 17, 2012

NOC Status at Filing:

Post NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Arthritis, juvenile idiopathic

Recommendation Type:

List with clinical criteria and/or conditions

Final Recommendation:

July 19, 2012

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Last Updated : January 30, 2012